India’s CRDMO sector growth potential at $22 – $25 bn by 2035: BCG-IPSO Report
Report states that India’s CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Funding in pharma plummets by 85 per cent in Feb 2025
As per data provided by Tracxn, the decline in investment activity makes February 2025 one of the lowest-funded months in the past…
Zydus launches ANVIMO for prevention of CMV
Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…
Venus Remedies gains global marketing authorisation for Sugammadex from the Philippines
The global Sugammadex market, valued at approximately 1.53 billion in 2023, is projected to grow at a CAGR of 8.5 per cent,…
Glenmark USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose…
Glenmark acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA
Fragile X syndrome market to quadruple to $111.9 million in US and Germany by 2030, forecasts…
Targeted therapies poised to transform Fragile X syndrome market with 4X growth by 2030
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Novel therapies and regulatory shifts drive growth in the Duchenne muscular dystrophy market, with exon-skipping therapies leading…
Obesity market to reach $173.5 billion sales in 7MM by 2031, forecasts GlobalData
Growing patient awareness and emerging therapies drive obesity drug market expansion across the US, Europe, and Japan
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global…
IXP launches Lifesciences catalyst fund for early-stage investments
Fund targets INR 200 crore corpus with focus on biotech, pharma, and medical
India Ratings and Research maintains Neutral Outlook for pharmaceuticals sector in FY26
Revenue growth projected at 9 % -10 % year-on-year; operating margins expected to remain stable
Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025
Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
Pharma funding surges 191% in January 2025 to $300 million
Private equity rounds drive majority of investments; Neuberg Diagnostics, Aragen, and Foxtale secure top deals
Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy…
The industry’s outlook remains uncertain as it navigates complex economic and political dynamics, reveals GlobalData
Lupin and Avas launch NaMuscla in Italy
Avas will initially commercialise NaMuscla as a Class C (Tier 2), while Lupin negotiates with AIFA (Agenzia Italiana del Farmaco)…
APAC healthcare market to hit $ 5 Tn by 2030, states BCG Report
Key growth areas across subsectors include contract manufacturing and research, and innovation-driven biotech
Kotak Alternate Asset Managers announces first close of Kotak Life Sciences Fund
INR 1600 crore fund to invest in early to growth stage companies across the Life Science and Healthcare Segment
Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection, USP in the US
This launch is the latest in a series of recent product launches from the company in the generic injectables market
Biotech startup Exsure raises Rs 3 Cr in Seed round led by Unicorn India Ventures
Exsure is a biotech startup working to reduce the side effects and toxicity of anti-cancer drugs by its patented exosomal…
Kenvue launches WHO-approved Ready-to-Drink ORS
The new product offers 100 per cent assured WHO Osmolarity supporting faster recovery from diarrhoea, mitigating water…